A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs.


Journal

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
ISSN: 1553-2712
Titre abrégé: Acad Emerg Med
Pays: United States
ID NLM: 9418450

Informations de publication

Date de publication:
05 2021
Historique:
revised: 05 12 2020
received: 17 09 2020
accepted: 17 12 2020
pubmed: 22 12 2020
medline: 8 6 2021
entrez: 21 12 2020
Statut: ppublish

Résumé

Emergency medicine clinicians are uniquely positioned to deliver interventions to enhance linkage to evidence-based treatment for opioid use disorder (OUD) in the acute overdose period, yet little is known about patient perspectives to effectively engage patients immediately following opioid overdose. Our objective was to explore patients' perspectives on substance use treatment, perceived needs, and contextual factors that shape the choice of patients seen in the emergency department (ED) to engage with treatment and other patient support services in the acute post-opioid overdose period. We administered a brief quantitative survey and conducted semistructured interviews with 24 adult ED patients receiving care after an acute opioid overdose between June 2016 and August 2017 in an urban, academic ED. We used constant comparison method and thematic analysis to identify themes across four levels of a modified social ecologic model (individual, interpersonal, organizational, and structural). The mean (±SD) age of the sample was 33.5 (±9.33) years; 83% were White and 12% were Black; 67% were male; and 83% were diagnosed with OUD, with a mean (±SD) of 3.25 (±2.64) self-reported lifetime opioid overdoses. Eight themes were identified as influencing participants' consideration of OUD treatment and other services: (1) perceptions about control of drug use, (2) personal experience with substance use treatment, (3) role of interpersonal relationships, (4) provider communication skills, (5) stigma, (6) availability of ED resources, (7) impact of treatment policies, and (8) support for unmet basic needs. Patients receiving ED care following overdose in our ED are willing to discuss their opioid use and its treatment in the ED and report a variety of unmet needs. This work supports a role for ED-based research evaluating a patient-oriented approach to engage patients after opioid overdose.

Identifiants

pubmed: 33346926
doi: 10.1111/acem.14197
pmc: PMC8281441
mid: NIHMS1703264
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

542-552

Subventions

Organisme : NIDA NIH HHS
ID : K12 DA033312
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© 2020 by the Society for Academic Emergency Medicine.

Références

Ann Epidemiol. 2015 Aug;25(8):613-619.e2
pubmed: 25935710
JAMA Netw Open. 2020 Feb 5;3(2):e1920622
pubmed: 32022884
J Rural Health. 2016 Winter;32(1):92-101
pubmed: 26184098
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):288-93
pubmed: 24751432
Ann Emerg Med. 2020 Jan;75(1):13-17
pubmed: 31229387
Addiction. 2008 Mar;103(3):462-8
pubmed: 18190664
Ann Emerg Med. 2019 Nov;74(5):691-696
pubmed: 31272821
Int J Ment Health Addict. 2013 Feb 1;11(1):110-122
pubmed: 23956702
J Subst Abuse Treat. 2020 Jan;108:55-64
pubmed: 31277891
J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S39-45
pubmed: 21317593
BMJ. 2013 Jan 30;346:f174
pubmed: 23372174
Acad Emerg Med. 2010 Aug;17(8):903-11
pubmed: 20670330
Addiction. 2019 Aug;114(8):1379-1386
pubmed: 30851220
Acad Emerg Med. 2016 Apr;23(4):455-65
pubmed: 26816030
Ann Emerg Med. 2019 Mar;73(3):237-247
pubmed: 30318376
Int J Drug Policy. 2010 Mar;21(2):122-4
pubmed: 19931444
Am J Drug Alcohol Abuse. 2019;45(4):333-340
pubmed: 31084515
Addiction. 2007 Feb;102(2):264-70
pubmed: 17222281
Am J Psychiatry. 2018 Oct 1;175(10):970-978
pubmed: 30068260
Am J Addict. 2008 Sep-Oct;17(5):372-86
pubmed: 18770079
J Subst Abuse Treat. 2007 Jul;33(1):91-8
pubmed: 17588494
Prev Med. 2019 Nov;128:105813
pubmed: 31437462
Int J Drug Policy. 2018 Jul;57:104-110
pubmed: 29715589
J Acquir Immune Defic Syndr (1988). 1993 Sep;6(9):1049-56
pubmed: 8340896
Psychiatr Serv. 2014 Feb 1;65(2):158-70
pubmed: 24247147
J Psychoactive Drugs. 2015 Apr-Jun;47(2):149-57
pubmed: 25950595
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699
Drug Alcohol Depend. 2016 Jun 01;163:40-7
pubmed: 27062245
Am J Drug Alcohol Abuse. 2019;45(1):1-10
pubmed: 30675818
Inj Prev. 2019 Jun;25(3):191-198
pubmed: 29436397
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002209
pubmed: 19588333
Subst Abuse Treat Prev Policy. 2019 Sep 11;14(1):37
pubmed: 31511016
Addiction. 2019 Aug;114(8):1396-1404
pubmed: 30916463
N Engl J Med. 2018 Dec 27;379(26):2487-2490
pubmed: 30586522
MMWR Morb Mortal Wkly Rep. 2018 Mar 09;67(9):279-285
pubmed: 29518069
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
pubmed: 10170434
BMC Health Serv Res. 2019 Dec 11;19(1):957
pubmed: 31829228
Addiction. 2016 Jul;111(7):1177-87
pubmed: 27028542
Acad Emerg Med. 2015 Sep;22(9):1103-12
pubmed: 26284572
Acad Emerg Med. 2005 Mar;12(3):249-56
pubmed: 15741590
JAMA. 2015 Apr 28;313(16):1636-44
pubmed: 25919527
Am J Psychol. 2013 Summer;126(2):155-77
pubmed: 23858951
R I Med J (2013). 2014 Oct 01;97(10):38-9
pubmed: 25271659
Ann Intern Med. 2018 Aug 7;169(3):137-145
pubmed: 29913516
J Subst Abuse Treat. 2018 Nov;94:29-34
pubmed: 30243414
Ann Intern Med. 2013 Jan 1;158(1):1-9
pubmed: 23277895
Mol Psychiatry. 2019 Dec;24(12):1868-1883
pubmed: 29934549
Subst Abus. 2020;41(4):519-525
pubmed: 31638862
Lancet. 2003 Feb 22;361(9358):662-8
pubmed: 12606177
Ann Emerg Med. 2012 Aug;60(2):181-92
pubmed: 22459448
Cochrane Database Syst Rev. 2014 Feb 06;(2):CD002207
pubmed: 24500948
Am J Public Health. 2014 Aug;104(8):e32-42
pubmed: 24922138
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
Am J Public Health. 2013 May;103(5):917-22
pubmed: 23488511
Drug Alcohol Depend. 2009 Aug 1;103(3):148-54
pubmed: 19443133
Behav Modif. 2002 Apr;26(2):223-73
pubmed: 11961914

Auteurs

Kathryn Hawk (K)

Department of Emergency Medicine, Yale University, New Haven, Connecticut, USA.

Lauretta E Grau (LE)

School of Public Health, Yale University, New Haven, Connecticut, USA.

David A Fiellin (DA)

Department of Emergency Medicine, Yale University, New Haven, Connecticut, USA.
Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.

Marek Chawarski (M)

Department of Psychiatry, Yale University, New Haven, Connecticut, USA.

Patrick G O'Connor (PG)

Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.

Nikolas Cirillo (N)

Department of Emergency Medicine, Yale University, New Haven, Connecticut, USA.
Department of Psychology, Nova Southeastern University, Fort Lauderdale, Florida, USA.

Chris Breen (C)

Department of Emergency Medicine, Yale University, New Haven, Connecticut, USA.
School of Medicine, Yale University, New Haven, Connecticut, USA.

Gail D'Onofrio (G)

Department of Emergency Medicine, Yale University, New Haven, Connecticut, USA.
School of Public Health, Yale University, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH